Administration of IV Laronidase Post Bone Marrow Transplant in Hurler

NCT01173016 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Hurler Syndrome

Interventions

DRUG: Laronidase

Sponsor

Masonic Cancer Center, University of Minnesota